Exclusive | Goldman Sachs Private Equity in talks to buy minority stake in IPO-bound Biocon Biologics

Exclusive | Goldman Sachs Private Equity in talks to buy minority stake in IPO-bound Biocon Biologics If the deal — which may value the firm in excess of $3.5 billion — fructifies, it would mark the third successive investment in 2020 for Kiran Mazumdar Shaw-led Biocon Biologics

from Moneycontrol Business News https://www.moneycontrol.com/news/business/exclusive-|-goldman-sachs-private-equitytalks-to-buy-minority-stakeipo-bound-biocon-biologics_14328581.html
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...